ClinicalTrials.gg
RecruitingNCT06122298TIGERUpdated Jul 17, 2025

Testing the Interplay of Gambling, Emotion and Reward

An observational study in Gambling Addiction, sponsored by Hôpital le Vinatier. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-17.

Sponsored by Hôpital le Vinatier · Observational

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 7 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Background The nature and direction of dysfunctional reward processing in gambling disorder remains unclear. We aim to test a novel neurobiological model of gambling addiction, that takes into account inter-individual differences, as well as the multifactorial nature of gaming addiction.

Objectives

Primary objective:

This project will test the hypothesis that there are two opposite brain phenotypes that characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.

Secondary objective:

This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory.

Study design The primary objective will be tested using a reward task and a facial emotion recognition task performed by participants in an fMRI scanner.

The secondary objective will be tested by combining fMRI measures with behavioral measures from everyday life collected via Ecological Momentary Assessment (EMA).

Study population This study will focus on individuals with gambling problems, as well healthy subjects with no gambling problems and no psychiatric comorbidities.

Outcomes/Endpoints

Primary endpoint:

We will compare striatum and amygdala reactivity between the three groups of impulsive gamblers, emotional gamblers and healthy subjects.

Secondary endpoint:

We will assess the correlation between emotional states and gambling behavior in everyday life, based on striatum and amygdala reactivity, using multiple linear regression models.

Read the detailed description

Background Gambling addiction has often been conceptualized as the result of reward processing dysfunction in the brain, particularly in the striatum, a key structure of the reward system. Although a number of studies have provided support for this hypothesis, neuroimaging studies have produced inconsistent results, suggesting either hypo- or hyper-reactivity to rewards in gambling addiction. These inconsistencies have been the subject of intense debate, but remain unexplained to this day, hampering our understanding of the disease and the development of effective therapeutic strategies. The aim of this project is to test a new neurobiological model of gambling addiction that has the potential to reconcile these inconsistencies. A particular feature of this model is that it takes into account inter-individual differences, as well as the multifactorial nature of gaming addiction.

Objectives

Primary objective:

This project will test the hypothesis that there are two opposite brain phenotypes in gambling addiction: striatal hyper-reactivity to reward combined with amygdala hypo-reactivity to emotional stimuli, and striatal hypo-reactivity to reward combined with amygdala hyper-reactivity to emotional stimuli. The investigators further hypothesize that these two brain phenotypes characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.

Secondary objective:

This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory. To do this, the investigators will use Ecological Momentary Assessment (EMA), which involves using participants' smartphones to perform repeated, real-time sampling of their gambling behavior and emotions in real life. The investigators hypothesize that a significant difference in reactivity between the striatum and the amygdala will be associated with a strong correlation between 1) gambling behavior and positive emotions in impulsive gamblers, and 2) gambling behavior and negative emotions in emotional gamblers.

Study design The primary hypothesis will be tested using cognitive tasks performed by participants in an fMRI scanner. In order to assess striatal reactivity to reward, the investigators will use fMRI combined with a reward task. The investigators will use fMRI combined with a facial emotion recognition task to measure the reactivity of the amygdala to emotional stimuli. These tasks will allow the investigators to establish the brain phenotypes characterizing impulsive and emotional gamblers, and test the hypothesis that these phenotypes are diametrically opposed in these two sub-populations.

The secondary hypothesis will be tested by combining fMRI measures with behavioral measures from everyday life (EMA). In concrete terms, gamblers will be followed longitudinally for up to 4 weeks, and will receive short questionnaires 3 to 4 times a day on their smartphones to assess their gambling behavior (number of hours spent gambling, amount of money spent...) as well as their emotions (positive and negative). These measurements will enable the investigators to test the hypothesis that the brain phenotypes described above are capable of predicting the relationship between emotions and gambling behavior in everyday life.

Study population This study will focus on individuals with gambling problems. This category includes individuals suffering from gambling addiction as defined by the DSM-5, and individuals suffering from "problem gambling", just below the DSM-5 diagnostic threshold. Extending recruitment to individuals with problem gambling should facilitate recruitment, while considering the existence of a continuum of gambling problems.

The study will also include a control group of healthy subjects with no gambling problems and no psychiatric comorbidities.

The plan is to recruit 60 gamblers and 60 healthy controls.

02

Conditions studied

  • Gambling Addiction

Browse trials for

Keywords

  • gambling addiction
  • fMRI
  • reward
  • emotion
  • striatum
  • amygdala
  • EMA
03

In context

Gambling

158 studies on the registry are indexed under Gambling; 42 are open to participants now.

This study's planned enrollment of 120 is below the median of 213 across 23 observational studies indexed under Gambling.

Browse Gambling studies →

Lead sponsor

Hôpital le Vinatier is the lead sponsor of 106 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Two groups: 60 individuals with gambling problems (i.e. Number of DSM-5 critera for gambling disorder ≥3) and 60 matched healthy controls

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For all participants (gamblers and healthy subjects)

  • Aged between 18 and 65
  • Fluent French, read and spoken
  • Male and Female
  • to take part in the research

For gamblers :

  • Number of critera for gambling disorder ≥3
  • Score ≥ 5 on the Problem Gambling Severity Index questionnaire (PGSI)
  • Have a smartphone

For healthy subjects :

  • no DSM-5 criteria for gambling addiction
  • Score ≤ 2 on the Problem Gambling Severity Index questionnaire (PGSI)

Exclusion criteria

Exclusion Criteria:

For all participants (gamblers and healthy subjects):

  • to MRI
  • Protected Adults
  • Breast feeding or pregnant women
  • Neurological disorder or severe chronic illness (diabetes, heart disease, kidney disease, lung disease or liver disease, inflammatory disease….)
  • Pharmacological treatment with psychotropic action (>1 time / week)
  • Regular drug use (> 1 time/ week for at least 3 months in the last 6 months)
  • Positive urine drug test on the day of the MRI sessions

For gamblers:

  • Psychiatric treatment > 1 month (pharmacological or CBT)
  • Other diagnosis : schizophrenia, bipolar disorder, ADHD, autism, current PTSD, eating disorders, current major depressive episode, anxiety disorder, substance use disorder except nicotine, obsessive compulsive disorder.

For healthy subjects :

- Any DSM-5 diagnosis except nicotine addiction

Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Individuals with gambling problems

    This group includes individuals suffering from gambling addiction as defined by the DSM-5, and individuals suffering from "problem gambling", just below the DSM-5 diagnostic threshold.

    Other: fMRI · Other: Ecological Momentary Assessment

  • Healthy control individuals

    Matched healthy individuals

    Other: fMRI

Interventions

  • OtherfMRI

    A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.

  • OtherEcological Momentary Assessment

    studies people's thoughts and behaviour in their daily lives by repeatedly collecting data in an individual's normal environment, at or close to the time they carry out that behaviour

    Also known as: EMA

06

What researchers measure

Primary outcomes

  1. Striatal BOLD response to reward outcomes and amygdala BOLD response to emotional stimuli

    Striatal BOLD response: average BOLD signal as measured with fMRI in the striatum in response to monetary reward outcomes in a gambling task. amygdala BOLD response: average BOLD signal as measured with fMRI in the amygdala in response to emotional faces in a facial emotion recognition task.

    Time frame: 4 weeks

Secondary outcomes

  1. Correlation between emotional states and gambling behavior in everyday life

    Emotions and gambling behavior in everyday life will be measured using Ecological Momentary Assessment on gamblers' smartphones

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2024 (actual). Primary completion is estimated for May 2027, 37 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2023
First posted
Nov 8, 2023
StartActual
Mar 27, 2024
Primary completionEst.
May 20, 2027
CompletionEst.
May 20, 2028
Last update
Jul 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06122298
Responsible party
Sponsor
First posted
Nov 8, 2023
Start date
Mar 27, 2024
Primary completion
May 20, 2027 (estimated)
Completion
May 20, 2028 (estimated)
Last update
Jul 17, 2025

Study contacts

Guillaume SESCOUSSE, PHD
Contact
guillaume.sescousse@ch-le-vinatier.fr
0437915531 ext. +33
Guillaume SESCOUSSE, PHD
principal investigator · CH Le Vinatier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion